Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms

The New England Journal of Medicine
K M SullivanJ Hansen

Abstract

The occurrence of graft-versus-host disease (GVHD) after allogeneic bone marrow transplantation for leukemia is thought to decrease the probability of recurrence. To study this effect (called adoptive immunotherapy) we modified the prophylaxis of GVHD in patients with advanced hematologic neoplasms (mostly leukemia) who received bone marrow transplants. Patients under 30 years of age were randomly assigned to one of three regimens of post-transplantation immunosuppression: Group I (n = 44) received a standard course of methotrexate for 102 days after transplantation, Group II (n = 40) received an abbreviated (11-day) course of methotrexate, and Group III (n = 25) received the standard course of methotrexate plus viable buffy-coat cells from the marrow donors. All 109 patients received cyclophosphamide (60 mg per kilogram of body weight on each of two days), total-body irradiation (2.25 Gy daily for seven days), and unmodified marrow from HLA-identical sibling donors. The frequency of GVHD of Grades II through IV was 25 percent in Group I, 59 percent in Group II, and 82 percent in Group III (P = 0.0001). The incidence of chronic GVHD, however, did not differ significantly among the groups (33, 51, and 44 percent, respectively), ...Continue Reading

References

Feb 1, 1977·Annals of Internal Medicine·The UCLA Bone Marrow Transplantation Group
May 10, 1979·The New England Journal of Medicine·P L WeidenRainer Storb
Apr 17, 1975·The New England Journal of Medicine·E D ThomasC D Buckner
Jan 1, 1976·Annals of the New York Academy of Sciences·A FeferM A Cheever
Dec 1, 1987·Annals of Internal Medicine·J D MeyersK M Sullivan
Jan 1, 1986·International Journal of Cell Cloning·K M Sullivan
Oct 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S I BearmanE D Thomas
Apr 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stanley R RiddellE D Thomas
Sep 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D J WeisdorfJ H Kersey
Feb 1, 1986·Annals of Internal Medicine·R S WeinerA A Rimm
Nov 1, 1982·Reviews of Infectious Diseases·J D MeyersE D Thomas
Sep 1, 1983·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E D Thomas
Jan 1, 1982·Leukemia Research·C BadgerN Flournoy
Aug 1, 1980·The American Journal of Medicine·H M ShulmanE D Thomas
Jun 18, 1981·The New England Journal of Medicine·P L WeidenSeattle Marrow Transplant Team
Feb 1, 1980·International Journal of Radiation Oncology, Biology, Physics·W C LamE D Thomas
Jul 1, 1957·British Journal of Haematology·D W BARNES, J F LOUTIT

Citations

Aug 5, 2000·International Journal of Cancer. Journal International Du Cancer·V SchirrmacherM Rocha
May 1, 1996·Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·H R RosenR W Busuttil
Jan 1, 1992·Immunologic Research·A Butturini, R P Gale
Aug 7, 2003·Current Hematology Reports·Ginna G Laport
Jan 1, 1994·Medical Oncology·H M Lazarus, J M Rowe
Nov 15, 2002·International Journal of Hematology·Stanley R RiddellE H Warren
Nov 15, 2002·International Journal of Hematology·J L M Ferrara
Feb 1, 1995·Social Science & Medicine·N E BushK M Sullivan
Oct 1, 1991·Current Opinion in Immunology·M K Brenner, H E Heslop
Oct 23, 2004·Best Practice & Research. Clinical Haematology·Hans-Jochem KolbGeorg Ledderose
Jul 6, 2000·Immunopharmacology·L GenestierJ P Revillard
Mar 29, 2001·Experimental Hematology·H GokerN J Chao
Jul 5, 2003·Experimental Hematology·Imad A Tabbara, Richard M Ingram
Oct 1, 1996·Current Opinion in Immunology·R A Nash, Rainer Storb
Sep 6, 2003·Methods : a Companion to Methods in Enzymology·M A W G van der HoornJ H F Falkenburg
Jun 29, 2007·Nature Clinical Practice. Oncology·Ben SprangersAn D Billiau
Jan 5, 2005·Nature Reviews. Immunology·Paul Moss, Alan Rickinson
Mar 22, 2001·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·S ShiobaraY Kodera
Sep 13, 1990·The New England Journal of Medicine·K M SullivanR P Witherspoon
Jan 13, 1994·The New England Journal of Medicine·D L PorterJ H Antin
Mar 24, 1994·The New England Journal of Medicine·J O Armitage
Mar 2, 2011·Cancer Biotherapy & Radiopharmaceuticals·Robert O Dillman
Aug 1, 1995·Journal of Hematotherapy·L M SillaE D Ball
Mar 31, 2005·Journal of Clinical Gastroenterology·Arnold Wald
May 1, 1991·British Journal of Haematology·R P GaleA Butturini
Apr 1, 1990·European Journal of Clinical Investigation·Rainer Storb, C D Buckner
Aug 1, 1990·Postgraduate Medical Journal·N T O'Connor
Jun 6, 2007·The Journal of Clinical Investigation·Carl H June
Mar 23, 1996·Lancet·L F VerdonckE J Petersen
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·D BonnetStanley R Riddell
May 1, 1992·Leukemia & Lymphoma·P Ljungman, G Gahrton
Dec 30, 1998·Leukemia & Lymphoma·B K Link, G J Weiner
Apr 6, 2012·Expert Review of Hematology·Patrick J Hanley, Catherine M Bollard
Jun 13, 2009·Expert Opinion on Emerging Drugs·Yasser KhaledOleg Krijanovski
Sep 20, 2011·Best Practice & Research. Clinical Haematology·Patrick SchlegelPeter Lang
Apr 7, 2011·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·M Michallet
Sep 16, 2008·Best Practice & Research. Clinical Haematology·Nicole A Aqui, Carl H June
May 28, 2008·Best Practice & Research. Clinical Haematology·Noelle V Frey, David L Porter
May 28, 2008·Best Practice & Research. Clinical Haematology·E P Alyea
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J O CullisJ M Goldman
Jan 1, 1991·Leukemia Research·R P GaleP Reizenstein
Jun 9, 2006·Blood Reviews·Wendy IngramGhulam J Mufti
Sep 26, 2006·Best Practice & Research. Clinical Haematology·Frédéric Baron, Rainer Storb
Aug 1, 1989·British Journal of Haematology·A Butturini, R P Gale
Mar 1, 1991·The Journal of Pediatrics·Rainer Storb
Sep 24, 2002·Hematology·Karl S Peggs, Stephen Mackinnon
Feb 19, 2004·Seminars in Oncology·Athanasios AnagnastopoulosS Giralt
Oct 7, 2005·Critical Reviews in Oncology/hematology·Daniel H Fowler
Sep 10, 2003·Hematology/oncology Clinics of North America·Mary L Disis, Saul Rivkin
May 3, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Anita J KumarSteven C Goldstein
Nov 9, 2011·Clinical Lymphoma, Myeloma & Leukemia·R ChamplinMarcos De Lima
Dec 25, 2010·Acta Microbiologica Et Immunologica Hungarica·Joseph G Sinkovics
Jan 10, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Y ChalandonBernard Chapuis
Feb 11, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Massimo AgliettaEBMT Solid Tumor Working Party
Jul 30, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Robert L Truitt
Jun 15, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Darius SairafiJonas Mattsson
Feb 1, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Raymond WongS Giralt
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T L KissH A Messner
Nov 30, 1999·Hematology/oncology Clinics of North America·M E FlowersK M Sullivan
Apr 4, 2017·HLA : Immune Response Genetics·H-J Kolb
Dec 18, 2001·Journal of Clinical Apheresis·M KörblingR Champlin
Dec 1, 2011·Therapeutic Advances in Hematology·Alison Rager, David L Porter
Aug 3, 2002·Leukemia & Lymphoma·A B T FassasG Tricot
Nov 11, 2008·Bone Marrow Transplantation·R RamO Shpilberg
Jul 14, 2000·Journal of Hematotherapy & Stem Cell Research·S Morecki, S Slavin
Oct 19, 2004·Bone Marrow Transplantation·W W TseK Van Besien
Oct 16, 2004·Expert Review of Anticancer Therapy·Igor Espinoza-Delgado, Richard W Childs
Dec 29, 1995·Annals of the New York Academy of Sciences·Rainer StorbT Graham
May 10, 2005·Journal of Clinical Apheresis·J H Antin
Jul 28, 2009·Bone Marrow Transplantation·Y ChalandonChronic Leukemia Working Party of European Group for Blood and Marrow Transplantation
Dec 2, 2009·The Korean Journal of Internal Medicine·Masahiro Imamura, Junji Tanaka
Jul 4, 2001·Bone Marrow Transplantation·R ChamplinS Giralt
Nov 28, 2001·Hematology·Rainer StorbE H Warren
Sep 6, 2003·Blood·Hans-Jochem KolbDolores J Schendel
Nov 18, 2003·Transplant Infectious Disease : an Official Journal of the Transplantation Society·A BuscaM Falda
Aug 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H M LokhorstL F Verdonck
Feb 6, 2003·International Journal of Hematology·George E Georges, Rainer Storb
Dec 6, 2019·Frontiers in Oncology·Connor Sweeney, Paresh Vyas
Apr 20, 2002·Cancer Control : Journal of the Moffitt Cancer Center·Stanley R RiddellEdis H Warren
Jun 24, 2017·Frontiers in Immunology·Anne M DickinsonHans Jochem-Kolb
Nov 28, 2001·Hematology·F R AppelbaumJ E Dick
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D AdkinsJ DiPersio
Oct 25, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·B R BlazarP A Taylor
Apr 20, 2002·Cancer Control : Journal of the Moffitt Cancer Center·Leo Luznik, Ephraim J Fuchs
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L H SehnR J Soiffer
Dec 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Katayoun RezvaniA John Barrett

Related Concepts

Cyclophosphamide, (S)-Isomer
Graft-vs-Host Disease
Therapeutic Immunosuppression
Immunotherapy
Leukemia
Leukocytes
Lymphoma
Methotrexate, (DL)-Isomer
Pulmonary Fibrosis
Relapse

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.